These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 17970857)

  • 1. Current issues for nurse practitioners: Hyponatremia.
    Haskal R
    J Am Acad Nurse Pract; 2007 Nov; 19(11):563-79. PubMed ID: 17970857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition and treatment of hyponatremia in acutely ill hospitalized patients.
    Patel GP; Balk RA
    Clin Ther; 2007 Feb; 29(2):211-29. PubMed ID: 17472815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyponatremia: current treatment strategies and the role of vasopressin antagonists.
    Cawley MJ
    Ann Pharmacother; 2007 May; 41(5):840-50. PubMed ID: 17405824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasopressin excess and hyponatremia.
    Pham PC; Pham PM; Pham PT
    Am J Kidney Dis; 2006 May; 47(5):727-37. PubMed ID: 16632011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms, risks, and new treatment options for hyponatremia.
    Ghali JK
    Cardiology; 2008; 111(3):147-57. PubMed ID: 18434717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopressin antagonists: Pharmacotherapy for the treatment of heart failure.
    Reilly T; Schork MR
    Ann Pharmacother; 2010 Apr; 44(4):680-7. PubMed ID: 20332337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyponatremia in psychiatric patients: update on evaluation and management.
    Siegel AJ
    Harv Rev Psychiatry; 2008; 16(1):13-24. PubMed ID: 18306096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia.
    Palm C; Pistrosch F; Herbrig K; Gross P
    Am J Med; 2006 Jul; 119(7 Suppl 1):S87-92. PubMed ID: 16843091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hypervolemic or euvolemic hyponatremia associated with heart failure, cirrhosis, or the syndrome of inappropriate antidiuretic hormone with tolvaptan: a clinical review.
    Nemerovski C; Hutchinson DJ
    Clin Ther; 2010 Jun; 32(6):1015-32. PubMed ID: 20637957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia.
    Zeltser D; Rosansky S; van Rensburg H; Verbalis JG; Smith N;
    Am J Nephrol; 2007; 27(5):447-57. PubMed ID: 17664863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyponatremia, arginine vasopressin dysregulation, and vasopressin receptor antagonism.
    Rai A; Whaley-Connell A; McFarlane S; Sowers JR
    Am J Nephrol; 2006; 26(6):579-89. PubMed ID: 17170524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AVP receptor antagonists as aquaretics: review and assessment of clinical data.
    Verbalis JG
    Cleve Clin J Med; 2006 Sep; 73 Suppl 3():S24-33. PubMed ID: 16970150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressin dysregulation: hyponatremia, fluid retention and congestive heart failure.
    LeJemtel TH; Serrano C
    Int J Cardiol; 2007 Aug; 120(1):1-9. PubMed ID: 17346825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The therapeutic use of vaptans for the treatment of dilutional hyponatremia.
    Cassagnol M; Shogbon AO; Saad M
    J Pharm Pract; 2011 Aug; 24(4):391-9. PubMed ID: 21813818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel agents for the treatment of hyponatremia: a review of conivaptan and tolvaptan.
    Ferguson-Myrthil N
    Cardiol Rev; 2010; 18(6):313-21. PubMed ID: 20926941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current treatments and novel pharmacologic treatments for hyponatremia in congestive heart failure.
    Goldsmith SR
    Am J Cardiol; 2005 May; 95(9A):14B-23B. PubMed ID: 15847853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of arginine vasopressin receptor antagonists in hyponatremia in the elderly.
    Miller M
    Geriatrics; 2007 Jul; 62(7):20-6. PubMed ID: 17620018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of conivaptan hydrochloride, a vasopressin V(1A)/V(2)-receptor antagonist, in patients with euvolemic or hypervolemic hyponatremia and with or without congestive heart failure from a prospective, 4-day open-label study.
    Mao ZL; Stalker D; Keirns J
    Clin Ther; 2009 Jul; 31(7):1542-50. PubMed ID: 19695403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyponatremia, heart failure, and the role of tolvaptan.
    O'Connell JB; Alemayehu A
    Postgrad Med; 2012 Mar; 124(2):29-39. PubMed ID: 22437213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasopressin dysregulation and hyponatremia in hospitalized patients.
    Multz AS
    J Intensive Care Med; 2007; 22(4):216-23. PubMed ID: 17712057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.